Drug Shortage Report for MINT-METFORMIN
| Report ID | 74455 |
| Drug Identification Number | 02388766 |
| Brand name | MINT-METFORMIN |
| Common or Proper name | Metformin |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 count Bottles |
| ATC code | A10BA |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2019-02-04 |
| Estimated end date | Unknown |
| Actual end date | 2023-11-16 |
| Shortage status | Resolved |
| Updated date | 2024-12-05 |
| Company comments | Business Reasons. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-12-05 | French | Compare |
| v4 | 2024-12-05 | English | Compare |
| v3 | 2019-02-05 | English | Compare |
| v2 | 2019-02-04 | French | Compare |
| v1 | 2019-02-04 | English | Compare |
Showing 1 to 5 of 5